BioFocus exhibiting at booth 1347.  David Cronk, Senior Director Biology, Doris Hafenbradl, Senior Director Biology and Barbara Carlisle, Director Business Development North America are attending.

Tutorials:

Epigenetics Drug Discovery: Success Delivered by BioFocus – Tuesday 7th, 8:00 am – 8:50 am. Room 9, upper Level.

Doris Hafenbradl, Senior Director, Biology, BioFocus, Switzerland

BioFocus has identified a number of novel chemotypes leading into further optimization. The epigenetics drug discovery tool-box is continuously expanded:

• Design of efficient and selective inhibitors of epigenetics readers and writers using proprietary chemogenomics tools.
• Profiling strategies for lead optimization of epigenetics targets family inhibitors.

Fluorescence Lifetime Technology in Screening and Profiling – Tuesday 7th, 12:30 pm – 2:00 pm. Room 10.

Doris Hafenbradl, Senior Director, Biology, BioFocus, Switzerland

Fluorescence Lifetime technology (FLT) is a unique reading modality that provides a cost effective yet powerful and robust solution to screening that avoids the problems of compound interference whilst allowing profiling groups access to a wide range of assays catering for difficult to assay targets. FLT users from Large Pharma screening groups and CROs will relate their experiences as well as reagent and instrumentation providers.

Posters

• Computational approaches and new assay technologies for efficient hit finding against G9a and LSD1 (TP104)
• Facilitating drug discovery for epigenetic target classes using EpiRoadmap, an integrated chemogenomics tool

Click here for further details on the meeting.